Flagship Ventures Fund IV, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Flagship Ventures Fund IV, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Flagship Ventures Fund IV, L.P.. Flagship Ventures Fund IV, L.P. is 10% Owner in Eleven Biotherapeutics, Inc. ($EBIO) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Editas Medicine, Inc. ($EDIT).
Latest Insider Trading Transactions of Flagship Ventures Fund IV, L.P.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EDIT, SESN, SYRS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 54,293 | 0 | 0 | 54.3 K to 0 (-100.00 %) |
| Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 306,222 | 0 | 612,442 | 918.7 K to 612.4 K (-33.33 %) |
| Aug 21 2017 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 1,295,997 | 0 | 2,378,663 | 3.7 M to 2.4 M (-35.27 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.10 | 10,293 | 31,908 | 106,787 | 117.1 K to 106.8 K (-8.79 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.10 | 41,178 | 127,652 | 426,885 | 468.1 K to 426.9 K (-8.80 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.16 | 3,118 | 9,853 | 117,080 | 120.2 K to 117.1 K (-2.59 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.16 | 12,482 | 39,443 | 468,063 | 480.5 K to 468.1 K (-2.60 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.17 | 47,090 | 149,275 | 120,198 | 167.3 K to 120.2 K (-28.15 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.17 | 188,367 | 597,123 | 480,545 | 668.9 K to 480.5 K (-28.16 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.18 | 28,163 | 89,558 | 167,288 | 195.5 K to 167.3 K (-14.41 %) |
| Sep 26 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.18 | 112,731 | 358,485 | 668,912 | 781.6 K to 668.9 K (-14.42 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.75 | 64,509 | 241,909 | 195,451 | 260 K to 195.5 K (-24.81 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.75 | 258,214 | 968,303 | 781,643 | 1 M to 781.6 K (-24.83 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.39 | 10,778 | 36,537 | 259,960 | 270.7 K to 260 K (-3.98 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.39 | 43,139 | 146,241 | 1,039,857 | 1.1 M to 1 M (-3.98 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.31 | 1,939 | 6,418 | 270,738 | 272.7 K to 270.7 K (-0.71 %) |
| Sep 21 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 3.31 | 7,761 | 25,689 | 1,082,996 | 1.1 M to 1.1 M (-0.71 %) |
| Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.16 | 536 | 2,230 | 272,677 | 273.2 K to 272.7 K (-0.20 %) |
| Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.16 | 2,145 | 8,923 | 1,090,757 | 1.1 M to 1.1 M (-0.20 %) |
| Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.18 | 8,802 | 36,792 | 273,213 | 282 K to 273.2 K (-3.12 %) |
| Sep 16 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.18 | 35,209 | 147,174 | 1,092,902 | 1.1 M to 1.1 M (-3.12 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 8,145 | 36,734 | 282,015 | 290.2 K to 282 K (-2.81 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 32,597 | 147,012 | 1,128,111 | 1.2 M to 1.1 M (-2.81 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.51 | 52,985 | 238,962 | 1,833,802 | 1.9 M to 1.8 M (-2.81 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 3,108 | 14,390 | 290,160 | 293.3 K to 290.2 K (-1.06 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 12,441 | 57,602 | 1,160,708 | 1.2 M to 1.2 M (-1.06 %) |
| Sep 08 2016 | EBIO | Eleven Biotherapeu ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | S | 4.63 | 20,221 | 93,623 | 1,886,787 | 1.9 M to 1.9 M (-1.06 %) |
| Aug 15 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 50,271 | 0 | 0 | 50.3 K to 0 (-100.00 %) |
| Aug 15 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 691,060 | 991.1 K to 691.1 K (-30.27 %) |
| Aug 15 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Sell | J | 0.00 | 1,200,000 | 0 | 2,764,256 | 4 M to 2.8 M (-30.27 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 444,995 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,779,981 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,500,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 6,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 200,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 800,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | P | 12.50 | 80,000 | 1,000,000 | 918,664 | 838.7 K to 918.7 K (+9.54 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | P | 12.50 | 320,000 | 4,000,000 | 3,674,660 | 3.4 M to 3.7 M (+9.54 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 118,665 | 0 | 838,664 | 720 K to 838.7 K (+16.48 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 474,661 | 0 | 3,354,660 | 2.9 M to 3.4 M (+16.48 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 400,000 | 0 | 719,999 | 320 K to 720 K (+125.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 1,600,000 | 0 | 2,879,999 | 1.3 M to 2.9 M (+125.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 266,666 | 0 | 319,999 | 53.3 K to 320 K (+500.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 1,066,666 | 0 | 1,279,999 | 213.3 K to 1.3 M (+500.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 53,333 | 0 | 53,333 | 0 to 53.3 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 213,333 | 0 | 213,333 | 0 to 213.3 K |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 199,999 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,051,060 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,325,708 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 800,001 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 4,204,240 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 5,302,834 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 76,922 | 0 | 991,060 | 914.1 K to 991.1 K (+8.41 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 404,253 | 0 | 914,138 | 509.9 K to 914.1 K (+79.28 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 509,885 | 0 | 509,885 | 0 to 509.9 K |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 307,692 | 0 | 3,964,256 | 3.7 M to 4 M (+8.41 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 1,617,015 | 0 | 3,656,564 | 2 M to 3.7 M (+79.28 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 2,039,549 | 0 | 2,039,549 | 0 to 2 M |
Page: 1